October 2026
1. SAWAS T, Davitkov P, Zhou M, Eluri S, et al
   Adjunctive Use of p53 Immunohistochemistry for Risk Stratification in Barrett's Esophagus: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2026;121:2411-2422.
   

   >> Share

   
   September 2026
2. ISHIHARA R, Takahashi H, Abe S, Yoshio T, et al
   Long-term Outcomes After Endoscopic Resection for pMM/SM1 Esophageal Cancer: A Multicenter Prospective Cohort Study.
   Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004209.
   

   >> Share

   
   August 2026
3. GERBER A, Yoon JY, Hur C, Rubenstein JH, et al
   Greater Esophageal Cancer Burdens in Rural United States: A Surveillance, Epidemiology, and End Results Program Analysis.
   Am J Gastroenterol. 2026 Aug 28. doi: 10.14309/ajg.0000000000004189.
   

   >> Share

   
   
4. CHATTERJEE A, Abrams JA, Stachler MD
   Biomarker Use in Barrett's Esophagus Surveillance.
   Am J Gastroenterol. 2026;121:1813-1818.
   

   >> Share

   
   July 2026
5. BIAN Y, Xu Y, Chu C, Gao Y, et al
   Accurate Nonendoscopic Detection of Early Esophageal Squamous Malignant Lesions Using Sponge-Based Methylated DNA Biomarkers.
   Am J Gastroenterol. 2026;121:1600-1608.
   

   >> Share

   
   May 2026
6. MEN X, Wang Y, Zhao Y, Zhang H, et al
   Endoscopy-based Deep Learning Algorithms versus Endoscopists in Early Esophageal Squamous Cell Carcinoma Detection: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2026 May 26. doi: 10.14309/ajg.0000000000004067.
   

   >> Share

   
   April 2026
7. CODIPILLY DC, Faghani S, Vogelsang D, Moassefi M, et al
   Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation.
   Am J Gastroenterol. 2026;121:863-870.
   

   >> Share

   
   February 2026
8. WILSON NJ, Mordan N, Potrock C, Shaheen NJ, et al
   Screening for Barrett Esophagus and Esophageal Adenocarcinoma: Approaches and Outcomes.
   Am J Gastroenterol. 2026;121:302-311.
   

   >> Share

   
   January 2026
9. SAWAS T, Jones AR, Alsawas R, Talluri R, et al
   Overall and Cause-Specific Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-Analysis of Population-Based Studies.
   Am J Gastroenterol. 2026;121:140-150.
   

   >> Share

   
   December 2025
10. AKERSTROM JH, Santoni G, von Euler-Chelpin M, Birgisson H, et al
    Glucagon-like peptide-1 receptor agonist treatment and risk of esophageal cancer.
    Am J Gastroenterol. 2025 Dec 12. doi: 10.14309/ajg.0000000000003885.
    

    >> Share

    
    
11. WANG HH, Ono Y, Paulson TG, Grady WM, et al
    Gastric (Foveolar)-Type Dysplasia in Barrett's Esophagus: A Clinical, Molecular, and Long-Term Outcome Study.
    Am J Gastroenterol. 2025;120:2788-2794.
    

    >> Share

    
    November 2025
12. INAMDAR S
    Continuing Medical Education Questions: November 2025.
    Am J Gastroenterol. 2025;120:2483.
    

    >> Share

    
    
13. SKEF W, Haydel J, Rao A, Allencherril R, et al
    High Risk of Persistence and Risk of Dysplasia After Diagnosis of Ultrashort Barrett's Esophagus.
    Am J Gastroenterol. 2025;120:2520-2528.
    

    >> Share

    
    
14. INAMDAR S
    Continuing Medical Education Questions: November 2025.
    Am J Gastroenterol. 2025;120:2483.
    

    >> Share

    
    October 2025
15. KALRA A, Ma K, Cheng Y, Tsai HL, et al
    Discovery of Methylated DNA Biomarkers for Potential Nonendoscopic Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Am J Gastroenterol. 2025;120:2268-2279.
    

    >> Share

    
    August 2025
16. SHAH T, Ansari Z, Ahmad A, Coyle W, et al
    Spray Cryotherapy Esophageal Consortium (SPEC) Consensus Recommendations for Liquid Nitrogen Spray Cryotherapy in Barrett's Esophagus and Esophageal Cancer using a Modified Delphi Process.
    Am J Gastroenterol. 2025 Aug 26. doi: 10.14309/ajg.0000000000003752.
    

    >> Share

    
    April 2025
17. JACOBSON DH, Fitzgerald RC
    Barrett's Esophagus in Time and Space: A Methylation Panel for Tracking Esophageal Cancer.
    Am J Gastroenterol. 2025 Apr 7. doi: 10.14309/ajg.0000000000003378.
    

    >> Share

    
    
18. LIANG J, Rastegar R, El Helou M, Mathur K, et al
    Incidence Trends in Upper Gastrointestinal Cancer in Young Adults: A Nationwide Time-Trend Analysis Using 2001-2019 US Cancer Statistics Databases.
    Am J Gastroenterol. 2025;120:890-904.
    

    >> Share

    
    March 2025
19. GREER KB, Blum AE, Faulx AL, Deming EM, et al
    Nonendoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma in At-Risk Veterans.
    Am J Gastroenterol. 2025;120:545-553.
    

    >> Share

    
    February 2025
20. LAUN SE, Kann L, Braun J, Pierre F, et al
    Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus.
    Am J Gastroenterol. 2025;120:1285-1295.
    

    >> Share

    
    November 2024
21. SHAHEEN NJ, Othman MO, Taunk J, Chang KJ, et al
    Use of a Two-Gene Methylated DNA Biomarker Assay and Nonendoscopic Balloon for Detection of Barrett Esophagus Among High-Risk Individuals in a Screening Population.
    Am J Gastroenterol. 2024;120:1511-1520.
    

    >> Share

    
    
22. HUANG Y, Huang H, Wei T, Zhang A, et al
    Disparities, Trends, and Predictions to 2040 in Gastrointestinal Cancer Incidence, Mortality in the United States.
    Am J Gastroenterol. 2024;120:1367-1380.
    

    >> Share

    
    
23. MOINOVA HR, Verma S, Dumot J, Faulx A, et al
    Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Am J Gastroenterol. 2024;119:2206-2214.
    

    >> Share

    
    October 2024
24. SHAHEEN NJ, Odze RD, Singer ME, Salyers WJ, et al
    Adjunctive Use of Wide-Area Transepithelial Sampling-3D in Patients With Symptomatic Gastroesophageal Reflux Increases Detection of Barrett's Esophagus and Dysplasia.
    Am J Gastroenterol. 2024;119:1990-2001.
    

    >> Share

    
    September 2024
25. SIJBEN J, Rainey L, Maas F, Broeders MJM, et al
    The Public's Intended Uptake of Hypothetical Esophageal Adenocarcinoma Screening Scenarios: A Nationwide Survey.
    Am J Gastroenterol. 2024;119:1802-1812.
    

    >> Share

    
    
26. VANTANASIRI K, Joseph A, Sachdeva K, Goyal R, et al
    Rates of Recurrent Intestinal Metaplasia and Dysplasia After Successful Endoscopic Therapy of Barrett's Neoplasia by Endoscopic Mucosal Resection vs Endoscopic Submucosal Dissection and Ablation: A Large North American Multicenter Cohort.
    Am J Gastroenterol. 2024;119:1831-1840.
    

    >> Share

    
    August 2024
27. POMENTI SF, Flashner SP, Del Portillo A, Nakagawa H, et al
    Clinical and biological perspectives on non-canonical esophageal squamous cell carcinoma in rare subtypes.
    Am J Gastroenterol. 2024 Aug 21. doi: 10.14309/ajg.0000000000003041.
    

    >> Share

    
    
28. LAUN SE, Kann L, Braun J, Gilbert S, et al
    Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients With Barrett Esophagus.
    Am J Gastroenterol. 2024;120:1296-1306.
    

    >> Share

    
    July 2024
29. YOON JY, Lim F, Shah SC, Rubenstein JH, et al
    Endoscopic Surveillance of Intestinal Metaplasia of the Esophagogastric Junction: A Decision Modeling Analysis.
    Am J Gastroenterol. 2024;119:1289-1297.
    

    >> Share

    
    May 2024
30. KADOTA T, Abe S, Uedo N, Doyama H, et al
    Comparison of effective imaging modalities for detecting gastric neoplasms: A randomized three-arm phase II trial.
    Am J Gastroenterol. 2024 May 16. doi: 10.14309/ajg.0000000000002871.
    

    >> Share

    
    
31. CHANDAR AK, Keerthy K, Gupta R, Grady WM, et al
    Patients With Esophageal Adenocarcinoma With Prior Gastroesophageal Reflux Disease Symptoms Are Similar to Those Without Gastroesophageal Reflux Disease: A Cross-Sectional Study.
    Am J Gastroenterol. 2024;119:823-829.
    

    >> Share

    
    April 2024
32. KAMBOJ AK, Goyal R, Vantanasiri K, Sachdeva K, et al
    Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
    Am J Gastroenterol. 2024;119:662-670.
    

    >> Share

    
    February 2024
33. POKALA SK, Williams JL, Holub JL, Calderwood AH, et al
    Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic.
    Am J Gastroenterol. 2024;119:251-261.
    

    >> Share

    
    December 2023
34. JIANG H, Chen R, Li Y, Hao C, et al
    Performance of prediction models for esophageal squamous cell carcinoma in general population: a systematic review and external validation study.
    Am J Gastroenterol. 2023 Dec 13. doi: 10.14309/ajg.0000000000002629.
    

    >> Share

    
    November 2023
35. LOW EE, Demb J, Shah SC, Liu L, et al
    Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Utilizing the Nationwide Veterans Affairs Achalasia Cohort (VA-AC).
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002591.
    

    >> Share

    
    
36. NOURELDIN M, Rubenstein JH, Urias E, Berinstein JA, et al
    RACIAL DISPARITY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA TREATMENT AND SURVIVAL IN THE UNITED STATES.
    Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002606.
    

    >> Share

    
    
37. DUITS LC, Khoshiwal AM, Frei NF, Pouw RE, et al
    An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2023;118:2025-2032.
    

    >> Share

    
    October 2023
38. JIANG H, Xin L, Wang L
    Management of Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa or Shallow Submucosal Layer After Endoscopic Resection.
    Am J Gastroenterol. 2023;118:1900.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share